{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:38:24Z","timestamp":1790843904019,"version":"4.1.0"},"reference-count":179,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270479"],"award-info":[{"award-number":["81270479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81460116"],"award-info":[{"award-number":["81460116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470832"],"award-info":[{"award-number":["81470832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670507"],"award-info":[{"award-number":["81670507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2017.00168","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T00:39:00Z","timestamp":1493944740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":151,"title":["Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance"],"prefix":"10.3389","volume":"7","author":[{"given":"Yi","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nong-Hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3343\/alm.2013.33.6.415","article-title":"Antibiotic resistance in Helicobacter pylori strains and its effect on H. pylori eradication rates in a single center in Korea","volume":"33","author":"An","year":"2013","journal-title":"Ann. Lab. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/01.mcg.0000129061.54277.c6","article-title":"Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection: results of a randomized controlled study","volume":"38","author":"Anagnostopoulos","year":"2004","journal-title":"J. Clin. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/hel.12291","article-title":"The changing profile of Helicobacter pylori antibiotic resistance in Singapore: a 15-year study","volume":"21","author":"Ang","year":"2016","journal-title":"Helicobacter"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1099\/jmm.0.010876-0","article-title":"Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori","volume":"58","author":"Anoushiravani","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/hel.12126","article-title":"High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections","volume":"19","author":"Attumi","year":"2014","journal-title":"Helicobacter"},{"key":"B6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/1751-2980.12271","article-title":"Susceptibility of Helicobacter pylori to antibiotics in Chinese patients","volume":"16","author":"Bai","year":"2015","journal-title":"J. Dig. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.clinre.2013.02.003","article-title":"Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco)","volume":"37","author":"Benajah","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.17219\/acem\/44372","article-title":"The prevalence of Helicobacter pylori infection in symptomatic children: a 13-year observational study in the lower Silesian region","volume":"25","author":"Biernat","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1136\/gut.37.4.477","article-title":"Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori","volume":"37","author":"Borody","year":"1995","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/hel.12219","article-title":"High-level primary clarithromycin resistance of Helicobacter pylori in Morocco: a prospective multicenter molecular study","volume":"20","author":"Bouilhat","year":"2015","journal-title":"Helicobacter"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1017\/S0950268814001770","article-title":"Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska","volume":"143","author":"Bruce","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America","volume":"109","author":"Camargo","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"B13","first-page":"1468","article-title":"High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study","volume":"16","author":"Candelli","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijantimicag.2006.11.007","article-title":"Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility","volume":"29","author":"Cattoir","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2750","DOI":"10.1097\/md.0000000000002750","article-title":"Tailored therapy versus empiric chosen treatment for Helicobacter pylori eradication: a meta-analysis","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e111030","DOI":"10.1371\/journal.pone.0111030","article-title":"The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis","volume":"9","author":"Dang","year":"2014","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4314\/gmj.v49i3.4","article-title":"Changing Patterns of the prevalence of Helicobacter pylori among patients at a corporate hospital in Ghana","volume":"49","author":"Darko","year":"2015","journal-title":"Ghana Med. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1523-5378.2010.00766.x","article-title":"Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children","volume":"15","author":"Dattoli","year":"2010","journal-title":"Helicobacter"},{"key":"B19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1572-0241.2007.01085.x","article-title":"Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics","volume":"102","author":"de Bortoli","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/apt.13364","article-title":"Prevalence and risk factors of Helicobacter pylori infection in asymptomatic Chinese children: a prospective, cross-sectional, population-based study","volume":"42","author":"Ding","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/mdr.2015.0209","article-title":"High-level primary clarithromycin resistance of Helicobacter pylori in Algiers, Algeria: a prospective multicenter molecular study","volume":"22","author":"Djennane-Hadibi","year":"2016","journal-title":"Microb. Drug Resist."},{"key":"B22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/hel.12241","article-title":"First-line bismuth-containing five-day concomitant quintuple therapy for Helicobacter pylori eradication","volume":"21","author":"Dolapcioglu","year":"2016","journal-title":"Helicobacter"},{"key":"B23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving Helicobacter pylori eradication with triple therapy","volume":"65","author":"Dore","year":"2016","journal-title":"Gut"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3201\/eid1006.030744","article-title":"Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States","volume":"10","author":"Duck","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1523-5378.2009.00670.x","article-title":"Urea breath test in children: the United States prospective, multicenter study","volume":"14","author":"Elitsur","year":"2009","journal-title":"Helicobacter"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/hel.12237","article-title":"Emerging role of probiotics in the management of Helicobacter pylori infection: histopathologic perspectives","volume":"21","author":"Emara","year":"2016","journal-title":"Helicobacter"},{"key":"B27","first-page":"39","article-title":"Seroepidemiology of Helicobacter pylori infection among children seen in a tertiary hospital in Uyo, southern Nigeria","volume":"12","author":"Etukudo","year":"2012","journal-title":"Pan. Afr. Med. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/archinte.158.15.1651","article-title":"A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori","volume":"158","author":"Fennerty","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/00042737-200210000-00013","article-title":"Reinfection rate in children after successful Helicobacter pylori eradication","volume":"14","author":"Feydt-Schmidt","year":"2002","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"g3174","DOI":"10.1136\/bmj.g3174","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials","volume":"348","author":"Ford","year":"2014","journal-title":"BMJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7361","DOI":"10.3748\/wjg.14.7361","article-title":"Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis","volume":"14","author":"Ford","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1523-5378.2010.00788.x","article-title":"The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China","volume":"15","author":"Gao","year":"2010","journal-title":"Helicobacter"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1128\/AAC.47.9.2984-2986.2003","article-title":"Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori","volume":"47","author":"Gerrits","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/AAC.46.9.2996-3000.2002","article-title":"16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori","volume":"46","author":"Gerrits","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/j.1572-0241.2005.50043.x","article-title":"The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review","volume":"100","author":"Gisbert","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s100960100611","article-title":"European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori","volume":"20","author":"Glupczynski","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1574-695X.2006.00209.x","article-title":"Differentially expressed genes in response to amoxicillin in Helicobacter pylori analyzed by RNA arbitrarily primed PCR","volume":"50","author":"Godoy","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-5378.2011.00874.x","article-title":"Epidemiology of Helicobacter pylori infection and public health implications","volume":"16","author":"Goh","year":"2011","journal-title":"Helicobacter"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1365-2036.2012.05054.x","article-title":"High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures","volume":"35","author":"Goh","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2958.1998.00806.x","article-title":"Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase","volume":"28","author":"Goodwin","year":"1998","journal-title":"Mol. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3904\/kjim.2015.30.2.133","article-title":"Roadmap for elimination of gastric cancer in Korea","volume":"30","author":"Graham","year":"","journal-title":"Korean J. Intern. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/hel.12244","article-title":"Editorial-avoiding unethical Helicobacter pylori clinical trials: susceptibility-based studies and probiotics as adjuvants","volume":"20","author":"Graham","year":"","journal-title":"Helicobacter"},{"key":"B44","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/gutjnl-2016-311796","article-title":"Vonoprazan Helicobacter pylori eradication therapy: ethical and interpretation issues","volume":"66","author":"Graham","year":"2017","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/14787210.2016.1178065","article-title":"Helicobacter pylori therapy: a paradigm shift","volume":"14","author":"Graham","year":"2016","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"B47","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00535-010-0220-x","article-title":"pylori therapy: studies from the United States","volume":"45","author":"Graham","year":"2010","journal-title":"J. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cgh.2013.05.028","article-title":"Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence","volume":"12","author":"Graham","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A report card to grade Helicobacter pylori therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"key":"B50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1523-5378.2006.00396.x","article-title":"High rate of Helicobacter pylori reinfection in children and adolescents","volume":"11","author":"Halitim","year":"2006","journal-title":"Helicobacter"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8547686","DOI":"10.1155\/2016\/8547686","article-title":"Multicenter study of antibiotic resistance profile of H. pylori and distribution of CYP2C19 gene polymorphism in rural population of chongqing, China","volume":"2016","author":"Han","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3748\/wjg.v10.i7.1075","article-title":"New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China","volume":"10","author":"Hao","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1128\/AAC.44.4.1075-1077.2000","article-title":"Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis","volume":"44","author":"Heep","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1111\/j.1440-1746.2009.06220.x","article-title":"Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori","volume":"25","author":"Hirata","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/jgh.12795","article-title":"Prevalence of Helicobacter pylori infection with healthy subjects in Japan","volume":"29","author":"Hirayama","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1093\/jac\/dkw118","article-title":"Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial","volume":"71","author":"Hong","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1124\/jpet.110.170274","article-title":"1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamin e monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases","volume":"335","author":"Hori","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1124\/jpet.111.179556","article-title":"A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals","volume":"337","author":"Hori","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1523-5378.2009.00714.x","article-title":"Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan","volume":"14","author":"Horiki","year":"2009","journal-title":"Helicobacter"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e9836","DOI":"10.1371\/journal.pone.0009836","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","volume":"5","author":"Jakobsson","year":"2010","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5223\/pghn.2015.18.1.10","article-title":"Changing prevalence of Helicobacter pylori infections in Korean children with recurrent abdominal pain","volume":"18","author":"Jang","year":"2015","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e2831","DOI":"10.1097\/MD.0000000000002831","article-title":"The association of age and antibiotic resistance of Helicobacter Pylori: a study in Jiaxing City, Zhejiang province, China","volume":"95","author":"Ji","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4291\/wjgp.v7.i1.181","article-title":"High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients","volume":"7","author":"Jonaitis","year":"2016","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/hel.12193","article-title":"Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan","volume":"20","author":"Kamada","year":"2015","journal-title":"Helicobacter"},{"key":"B65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000369898","article-title":"The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece","volume":"90","author":"Karamanolis","year":"2014","journal-title":"Digestion"},{"key":"B66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1556\/030.62.2015.3.6","article-title":"Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland","volume":"62","author":"Karpinski","year":"2015","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1128\/AAC.44.8.2214-2216.2000","article-title":"Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan","volume":"44","author":"Kato","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"B68","first-page":"1584","article-title":"Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients","volume":"18","author":"Kim","year":"2008","journal-title":"J. Microbiol. Biotechnol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/hel.12018","article-title":"Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea","volume":"18","author":"Kim","year":"","journal-title":"Helicobacter"},{"key":"B70","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1471-230X-13-138","article-title":"Long-term follow up Helicobacter pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy","volume":"13","author":"Kim","year":"","journal-title":"BMC Gastroenterol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/hel.12117","article-title":"Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection","volume":"19","author":"Kim","year":"2014","journal-title":"Helicobacter"},{"key":"B72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ja.2008.6","article-title":"Genetic analysis of Helicobacter pylori clinical isolates suggests resistance to metronidazole can occur without the loss of functional rdxA","volume":"62","author":"Kim","year":"2009","journal-title":"J. Antibiot."},{"key":"B73","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1128\/JCM.00740-07","article-title":"Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005","volume":"45","author":"Kobayashi","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/hel.12272","article-title":"Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a systematic review","volume":"21","author":"Kocazeybek","year":"2016","journal-title":"Helicobacter"},{"key":"B75","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.3748\/wjg.v20.i43.16029","article-title":"CYP2C19 polymorphism influences Helicobacter pylori eradication","volume":"20","author":"Kuo","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1648047","article-title":"High dose ilaprazole\/amoxicillin as first-line regimen for Helicobacter pylori infection in Korea","volume":"2016","author":"Kwack","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"B77","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1053\/bega.2001.0188","article-title":"Current role of acid suppressants in Helicobacter pylori eradication therapy","volume":"15","author":"Labenz","year":"2001","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/j.1572-0241.1998.00602.x","article-title":"Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials","volume":"93","author":"Laine","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/hel.12031","article-title":"Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012","volume":"18","author":"Lee","year":"2013","journal-title":"Helicobacter"},{"key":"B80","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/gutjnl-2012-302240","article-title":"The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention","volume":"62","author":"Lee","year":"2013","journal-title":"Gut"},{"key":"B81","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.cgh.2013.01.008","article-title":"Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study","volume":"11","author":"Liang","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/hel.12052","article-title":"Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy","volume":"18","author":"Liao","year":"2013","journal-title":"Helicobacter"},{"key":"B83","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-230X-13-104","article-title":"Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Gastroenterol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0016-5085(99)70119-8","article-title":"The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies","volume":"116","author":"Lind","year":"1999","journal-title":"Gastroenterology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1016\/S0140-6736(16)31409-X","article-title":"Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial","volume":"388","author":"Liou","year":"2016","journal-title":"Lancet"},{"key":"B86","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MEG.0000000000000186","article-title":"Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection","volume":"27","author":"Liu","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/1751-2980.12034","article-title":"Fourth Chinese national consensus report on the management of Helicobacter pylori infection","volume":"14","author":"Liu","year":"2013","journal-title":"J. Dig. Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2016","journal-title":"Gut"},{"key":"B90","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3748\/wjg.v21.i2.661","article-title":"Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication","volume":"21","author":"Mansour-Ghanaei","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N Engl. J. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/2050640615617358","article-title":"Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events","volume":"4","author":"McFarland","year":"2016","journal-title":"United European Gastroenterol. J."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H. pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"key":"B95","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"B96","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3855\/jidc.1187","article-title":"Assessing the role of the RND efflux pump in metronidazole resistance of Helicobacter pylori by RT-PCR assay","volume":"5","author":"Mehrabadi","year":"2011","journal-title":"J. Infect. Dev. Ctries."},{"key":"B97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.7326\/0003-4819-136-1-200201010-00008","article-title":"Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999","volume":"136","author":"Meyer","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1523-5378.2009.00739.x","article-title":"A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection","volume":"15","author":"Minakari","year":"2010","journal-title":"Helicobacter"},{"key":"B99","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/gut.41.6.735","article-title":"One week triple therapy for Helicobacter pylori: a multicentre comparative study","volume":"41","author":"Misiewicz","year":"1997","journal-title":"Gut"},{"key":"B100","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0016-5085(98)70475-5","article-title":"A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China)","volume":"114","author":"Mitchell","year":"1998","journal-title":"Gastroenterology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e1002693","DOI":"10.1371\/journal.ppat.1002693","article-title":"Age of the association between Helicobacter pylori and man","volume":"8","author":"Moodley","year":"2012","journal-title":"PLoS Pathog."},{"key":"B102","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1128\/AAC.39.1.107","article-title":"Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori","volume":"39","author":"Moore","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"B103","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/hel.12175","article-title":"Low antibiotic resistance of Helicobacter pylori in The Netherlands","volume":"20","author":"Mourad-Baars","year":"2015","journal-title":"Helicobacter"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/gutjnl-2015-311304","article-title":"Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study","volume":"65","author":"Murakami","year":"2016","journal-title":"Gut"},{"key":"B105","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13099-016-0091-7","article-title":"Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA","volume":"8","author":"Nagy","year":"2016","journal-title":"Gut Pathog."},{"key":"B106","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1442-200X.2008.02587.x","article-title":"Changes in the presence of urine Helicobacter pylori antibody in Japanese children in three different age groups","volume":"50","author":"Naito","year":"2008","journal-title":"Pediatr. Int."},{"key":"B107","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/hel.12204","article-title":"Molecular detection of Helicobacter pylori and its antimicrobial resistance in Brazzaville, Congo","volume":"20","author":"Ngoyi","year":"2015","journal-title":"Helicobacter"},{"key":"B108","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/hel.12199","article-title":"The prevalence of Helicobacter pylori remains high in African American and Hispanic Veterans","volume":"20","author":"Nguyen","year":"2015","journal-title":"Helicobacter"},{"key":"B109","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MCG.0000000000000165","article-title":"Clarithromycin versus metronidazole as first-line Helicobacter pylori eradication: a multicenter, prospective, randomized controlled study in Japan","volume":"49","author":"Nishizawa","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1365-2036.2004.02274.x","article-title":"Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial","volume":"20","author":"Nista","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B111","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/hel.12270","article-title":"The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial","volume":"21","author":"Oh","year":"2016","journal-title":"Helicobacter"},{"key":"B112","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jac\/dkf140","article-title":"A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori","volume":"50","author":"Okamoto","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"B113","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/hel.12124","article-title":"Antimicrobial resistance and characteristics of eradication therapy of Helicobacter pylori in Japan: a multi-generational comparison","volume":"19","author":"Okamura","year":"2014","journal-title":"Helicobacter"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1111\/j.1572-0241.2006.00717.x","article-title":"The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis","volume":"101","author":"Padol","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2015-309197","article-title":"A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu county, China: baseline results and factors affecting the eradication","volume":"65","author":"Pan","year":"2016","journal-title":"Gut"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s10620-016-4091-8","article-title":"Helicobacter pylori clarithromycin resistance and treatment failure are common in the USA","volume":"61","author":"Park","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10552-012-0117-5","article-title":"Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)","volume":"24","author":"Porras","year":"2013","journal-title":"Cancer Causes Control"},{"key":"B118","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/mdr.2014.0019","article-title":"Evolution of amoxicillin resistance of Helicobacter pylori in vitro: characterization of resistance mechanisms","volume":"20","author":"Qureshi","year":"2014","journal-title":"Microb. Drug Resist."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e12327","DOI":"10.1111\/hel.12327","article-title":"Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany","volume":"22","author":"Regnath","year":"2017","journal-title":"Helicobacter."},{"key":"B120","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1128\/AAC.00445-08","article-title":"Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori","volume":"52","author":"Rimbara","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/jac\/dkn051","article-title":"Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori","volume":"61","author":"Rimbara","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B122","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1523-5378.2011.00912.x","article-title":"Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB","volume":"17","author":"Rimbara","year":"2012","journal-title":"Helicobacter"},{"key":"B123","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/apt.13474","article-title":"Review article: the prevalence of Helicobacter pylori and the incidence of gastric cancer across Europe","volume":"43","author":"Roberts","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4291\/wjgp.v5.i4.384","article-title":"Use of probiotics in the fight against Helicobacter pylori","volume":"5","author":"Ruggiero","year":"2014","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/apt.12492","article-title":"Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole","volume":"38","author":"Sahara","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B126","first-page":"759","article-title":"The therapeutic effect of probiotic bacteria on gastrointestinal diseases","volume":"22","author":"Sarowska","year":"2013","journal-title":"Adv. Clin. Exp. Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1136\/gut.43.2008.s56","article-title":"The life and death of Helicobacter pylori","volume":"43","author":"Scott","year":"1998","journal-title":"Gut"},{"key":"B128","first-page":"90","article-title":"Bismuth-based therapies for the first step eradication of Helicobacter pylori","volume":"17","author":"Sezgin","year":"2006","journal-title":"Turk. J. Gastroenterol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/jpet.111.185314","article-title":"Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamin e monofumarate (TAK-438)","volume":"339","author":"Shin","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.cgh.2015.02.005","article-title":"Antibiotic Resistance of Helicobacter pylori among male United States veterans","volume":"13","author":"Shiota","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B131","first-page":"710","article-title":"Emerging trends of antimicrobial resistance in Helicobacter pylori isolates obtained from Pakistani patients: the need for consideration of amoxicillin and clarithromycin","volume":"66","author":"Siddiqui","year":"2016","journal-title":"J. Pak. Med. Assoc."},{"key":"B132","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1523-5378.2009.00734.x","article-title":"Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year follow-up","volume":"15","author":"Silva","year":"2010","journal-title":"Helicobacter"},{"key":"B133","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/hel.12137","article-title":"Recurrence of Helicobacter pylori infection in Bolivian children and adults after a population-based \u201cscreen and treat\u201d strategy","volume":"19","author":"Sivapalasingam","year":"2014","journal-title":"Helicobacter"},{"key":"B134","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12275-013-3029-5","article-title":"Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori","volume":"51","author":"Smiley","year":"2013","journal-title":"J. Microbiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.dld.2014.08.038","article-title":"Prospective multi-region study on primary antibiotic resistance of Helicobacter pylori strains isolated from Chinese patients","volume":"46","author":"Song","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"B136","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/hel.12294","article-title":"Hybrid therapy as first-line regimen for Helicobacter pylori eradication in populations with high antibiotic resistance rates","volume":"21","author":"Song","year":"2016","journal-title":"Helicobacter"},{"key":"B137","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1523-5378.1996.tb00043.x","article-title":"Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori","volume":"1","author":"Stone","year":"1996","journal-title":"Helicobacter"},{"key":"B138","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/hel.12046","article-title":"Antibiotic resistance of Helicobacter pylori isolated in the southeast coastal region of China","volume":"18","author":"Su","year":"2013","journal-title":"Helicobacter"},{"key":"B139","first-page":"410","article-title":"Mutations in Helicobacter pylori porD and oorD genes may contribute to furazolidone resistance","volume":"47","author":"Su","year":"2006","journal-title":"Croat. Med. J."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e12319","DOI":"10.1111\/hel.12319","article-title":"Four-times-daily dosing of rabeprazole with sitafloxacin, high-dose amoxicillin, or both for metronidazole-resistant infection with Helicobacter pylori in Japan","volume":"22","author":"Sugimoto","year":"2017","journal-title":"Helicobacter"},{"key":"B142","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/apt.13280","article-title":"High Helicobacter pylori cure rate with sitafloxacin-based triple therapy","volume":"42","author":"Sugimoto","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B143","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1523-5378.2010.00758.x","article-title":"High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication","volume":"15","author":"Sun","year":"2010","journal-title":"Helicobacter"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/apt.13214","article-title":"Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection","volume":"41","author":"Szajewska","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2036.2010.04457.x","article-title":"Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment","volume":"32","author":"Szajewska","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B146","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/1756-0500-7-834","article-title":"Seroprevalence of Helicobacter pylori infection and its related risk factors in symptomatic patients in southern Ethiopia","volume":"7","author":"Tadesse","year":"2014","journal-title":"BMC Res. Notes"},{"key":"B147","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00535-012-0536-9","article-title":"Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan","volume":"47","author":"Take","year":"2012","journal-title":"J. Gastroenterol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1128\/AAC.47.12.3942-3944.2003","article-title":"Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori","volume":"47","author":"Tankovic","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"B149","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","article-title":"Review article: the global emergence of Helicobacter pylori antibiotic resistance","volume":"43","author":"Thung","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B150","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B151","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1365-2362.2009.02166.x","article-title":"Amoxicillin resistance with beta-lactamase production in Helicobacter pylori","volume":"39","author":"Tseng","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"key":"B152","doi-asserted-by":"publisher","first-page":"e0136775","DOI":"10.1371\/journal.pone.0136775","article-title":"Helicobacter pylori infection in Thailand: a nationwide study of the CagA phenotype","volume":"10","author":"Uchida","year":"2015","journal-title":"PLoS ONE"},{"key":"B153","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1440-1746.2007.04984.x","article-title":"Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy","volume":"23","author":"Uygun","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajg.2013.03.002","article-title":"Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens","volume":"14","author":"Vafaeimanesh","year":"2013","journal-title":"Arab J. Gastroenterol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.3748\/wjg.v20.i40.14973","article-title":"Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis","volume":"20","author":"Wang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000280318","article-title":"Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis","volume":"83","author":"Wang","year":"2011","journal-title":"Digestion"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e12324","DOI":"10.1111\/hel.12324","article-title":"The internalization of Helicobacter pylori plays a role in the failure of H. pylori eradication","volume":"22","author":"Wang","year":"2017","journal-title":"Helicobacter."},{"key":"B158","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MCG.0b013e318266f6cf","article-title":"Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy","volume":"47","author":"Wang","year":"2013","journal-title":"J. Clin. Gastroenterol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet"},{"key":"B160","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"B161","doi-asserted-by":"publisher","first-page":"11415","DOI":"10.3748\/wjg.v20.i32.11415","article-title":"Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection","volume":"20","author":"Xie","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1440-1746.2011.06815.x","article-title":"Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan","volume":"26","author":"Yamade","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/apt.12293","article-title":"National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index","volume":"37","author":"Yan","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B164","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cgh.2014.10.036","article-title":"High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infection","volume":"13","author":"Yang","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B165","first-page":"1759","article-title":"Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high- or low-incidence regions of gastric cancer in China","volume":"122","author":"Zhang","year":"2009","journal-title":"Chin. Med. J."},{"key":"B166","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.3748\/wjg.v21.i14.4345","article-title":"Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis","volume":"21","author":"Zhang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1136\/gutjnl-2015-309900","article-title":"Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy","volume":"64","author":"Zhang","year":"2015","journal-title":"Gut"},{"key":"B168","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.3748\/wjg.v21.i9.2786","article-title":"Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study","volume":"21","author":"Zhang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3748\/wjg.v16.i10.1279","article-title":"Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori","volume":"16","author":"Zhang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1751-2980.2010.00457.x","article-title":"Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance","volume":"11","author":"Zheng","year":"2010","journal-title":"J. Dig. Dis."},{"key":"B171","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/1751-2980.12440","article-title":"Recurrence of Helicobacter pylori infection and the affecting factors: a follow-up study","volume":"18","author":"Zhou","year":"2017","journal-title":"J. Dig. Dis."},{"key":"B172","first-page":"11","article-title":"A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication","volume":"116","author":"Zhou","year":"2003","journal-title":"Chin. Med. J."},{"key":"B173","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ajg.2014.26","article-title":"A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial","volume":"109","author":"Zhou","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/hel.12242","article-title":"Tailored versus triple plus bismuth or concomitant therapy as initial Helicobacter pylori treatment: a randomized trial","volume":"21","author":"Zhou","year":"2016","journal-title":"Helicobacter"},{"key":"B175","first-page":"5","article-title":"Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China","volume":"24","author":"Zhu","year":"2013","journal-title":"Turk. J. Gastroenterol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijmm.2016.04.003","article-title":"Primary resistance of Helicobacter pylori is still low in southern Austria","volume":"306","author":"Zollner-Schwetz","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1523-5378.2009.00716.x","article-title":"Meta-analysis: lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication","volume":"14","author":"Zou","year":"2009","journal-title":"Helicobacter"},{"key":"B178","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1111\/j.1572-0241.2007.01514_1.x","article-title":"A quintuple therapy for H. pylori eradication","volume":"102","author":"Zullo","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"B179","first-page":"448","article-title":"High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study","volume":"28","author":"Zullo","year":"2015","journal-title":"Ann. Gastroenterol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T19:15:48Z","timestamp":1719170148000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fcimb.2017.00168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":179,"alternative-id":["10.3389\/fcimb.2017.00168"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2017.00168","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]},"article-number":"168"}}